Publicaciones en las que colabora con Manuel E. Jiménez-Mejías (11)

2024

  1. Efficacy of Tamoxifen Metabolites in Combination with Colistin and Tigecycline in Experimental Murine Models of Escherichia coli and Acinetobacter baumannii

    Antibiotics, Vol. 13, Núm. 5

2022

  1. Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 1, pp. 14-21

  2. Repurposing of the tamoxifen metabolites in combination with tigecycline against Gram-negative bacteria.

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 11

2021

  1. Efficacy of lysophosphatidylcholine as direct treatment in combination with colistin against acinetobacter baumannii in murine severe infections models

    Antibiotics, Vol. 10, Núm. 2, pp. 1-8

  2. Potential tamoxifen repurposing to combat infections by multidrug-resistant gram-negative Bacilli

    Pharmaceuticals, Vol. 14, Núm. 6

  3. Repurposing of the tamoxifen metabolites to combat infections by multidrug-resistant gram-negative bacilli

    Antibiotics, Vol. 10, Núm. 3

  4. Repurposing of the tamoxifen metabolites to treat methicillin-resistant staphylococcus epidermidis and vancomycin-resistant enterococcus faecalis infections

    Microbiology Spectrum, Vol. 9, Núm. 2

2019

  1. Antibacterial activity of colloidal silver against Gram-negative and Gram-positive bacteria.

    Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria, Núm. 8

  2. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli

    International Journal of Antimicrobial Agents, Vol. 54, Núm. 4, pp. 507-512

2018

  1. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae

    Frontiers in Cellular and Infection Microbiology, Vol. 8

2016

  1. Efficacy of lysophosphatidylcholine in combination with antimicrobial agents against Acinetobacter baumannii in experimental murine peritoneal sepsis and pneumonia models

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 8, pp. 4464-4470